glp-1 rebound weight gain A Comprehensive Review on following Discontinuation of Glucagon‐Like Peptide‐1 Receptor Agonists for Obesity - Abdullah bin Ahmed - 2024 - Journal of Obesity Weaning Off GLP-1 Medications: A

ISBN 0-87666-567-9

Measured in Danish Kroner, this statement holds true through 1998

Both triple and dual receptor agonists show similar enhancement of cAMP production in comparison to single GLP-1 receptor agonists [75]

When combined with semaglutide (a GLP-1 agonist), the combination targets two separate appetite pathways simultaneously, producing greater weight loss than either drug alone

Available from: Accessed 25 May 2025

A source later claimed that he gave up on weight loss medication because of his teenage son forcing him to take accountability. Mason was the main reason Scott gave up on Mounjaro, the source told the Daily Mail